Tesamorelin
Also known as: Egrifta, TH9507
Tesamorelin is a stabilized growth-hormone-releasing hormone (GHRH) analog that has been studied clinically, including for the reduction of excess visceral abdominal fat in specific populations. It acts by stimulating endogenous growth-hormone release. This entry is informational and is not a recommendation to use the compound.
At a glance
| Category | Growth Hormone Secretagogues |
|---|---|
| Class | peptide, ghrh-analog, growth-hormone-secretagogue |
| Half-life | about 30 minutes |
| Typical route | subcutaneous |
| Common vial strengths | 1 mg, 2 mg |
| Storage | Lyophilized powder is commonly stored refrigerated; reconstituted solutions are typically used promptly and kept cold. |
Elimination curve
Full clearance milestones on the Tesamorelin half-life page.
Doing the vial math? The Tesamorelin reconstitution calculator converts mg to insulin-syringe units, free and without an account.
Questions, answered.
What is Tesamorelin?
What is Tesamorelin's half-life?
Is Tesamorelin the same as Egrifta or TH9507?
What do people log alongside Tesamorelin?
Educational information for people who track their protocols — not medical advice, and never a recommendation to use any compound. Always work with a qualified healthcare provider.
Track Tesamorelin with one-tap dose logs, estimated level charts, site rotation, and reminders — free for your first 3 days.